Pretreatment platelet-to-lymphocyte ratio (PLR) as a prognosticating indicator for gastric cancer patients receiving immunotherapy

por Gou, Miaomiao, Zhang, Yong
Publicado 2022

PD-1 inhibitors-based second-line therapy for metastatic gastric cancer

por Gou, Miaomiao, Zhang, Yong, Wang, Zhikuan, Dai, Guanghai
Publicado 2023

Efficacy and safety of nivolumab for metastatic biliary tract cancer

por Gou, Miaomiao, Zhang, Yong, Si, Haiyan, Dai, Guanghai
Publicado 2019

The Role of Serum CEA and CA19-9 in Efficacy Evaluations and Progression-Free Survival Predictions for Patients Treated with Cetuximab Combined with FOLFOX4 or FOLFIRI as a First-L...

por Jia, Jun, Zhang, Pengfei, Gou, Miaomiao, Yang, Fan, Qian, Niansong, Dai, Guanghai
Publicado 2019

Efficacy and safety of apatinib in patients with previously treated metastatic colorectal cancer: a real-world retrospective study

por Gou, Miaomiao, Si, Haiyan, Zhang, Yong, Qian, Niansong, Wang, Zhikuan, Shi, Weiwei, Dai, Guanghai
Publicado 2018

Neutrophil-to-Lymphocyte Ratio (NLR) Predicts PD-1 Inhibitor Survival in Patients with Metastatic Gastric Cancer

por Gou, Miaomiao, Qu, Tongtong, Wang, Zhikuan, Yan, Huan, Si, Yanhai, Zhang, Yong, Dai, Guanghai
Publicado 2021

Fruquintinib in Combination With PD-1 Inhibitors in Patients With Refractory Non-MSI-H/pMMR Metastatic Colorectal Cancer: A Real-World Study in China

por Gou, Miaomiao, Qian, Niansong, Zhang, Yong, Yan, Huan, Si, Haiyan, Wang, Zhikuan, Dai, Guanghai
Publicado 2022

Construction of a nomogram to predict the survival of metastatic gastric cancer patients that received immunotherapy

por Gou, Miaomiao, Qian, Niansong, Zhang, Yong, Wei, Lihui, Fan, Qihuang, Wang, Zhikuan, Dai, Guanghai
Publicado 2022

Hyperprogressive Disease Caused by PD-1 Inhibitors for the Treatment of Pan-Cancer

por Chen, Shiyun, Gou, Miaomiao, Yan, Huan, Fan, Mengjiao, Pan, Yuting, Fan, Runjia, Qian, Niansong, Dai, Guanghai
Publicado 2021

PD-1 Inhibitors Could Improve the Efficacy of Chemotherapy as First-Line Treatment in Biliary Tract Cancers: A Propensity Score Matching Based Analysis

por Gou, Miaomiao, Zhang, Yong, Liu, Tiee, Si, Haiyan, Wang, Zhikuan, Yan, Huan, Qian, Niansong, Dai, Guanghai
Publicado 2021

A composite indicator of derived neutrophil–lymphocyte ratio and lactate dehydrogenase correlates with outcomes in pancreatic carcinoma patients treated with PD-1 inhibitors

por Chen, Shiyun, Guo, Shiyuan, Gou, Miaomiao, Pan, Yuting, Fan, Mengjiao, Zhang, Nan, Tan, Zhaoli, Dai, Guanghai
Publicado 2022

The Prognostic Value of Pre-treatment Hemoglobin (Hb) in Patients With Advanced or Metastatic Gastric Cancer Treated With Immunotherapy

por Gou, Miaomiao, Zhang, Yong, Liu, Tiee, Qu, Tongtong, Si, Haiyan, Wang, Zhikuan, Yan, Huan, Qian, Niansong, Dai, Guanghai
Publicado 2021

Analysis of a Systemic Inflammatory Biomarker in Advanced Bile Tract Carcinoma Treated with Anti-PD-1 Therapy: Prognostic and Predictive Significance of Lung Immune Prognostic Inde...

por Pan, Yuting, Si, Hanyan, Jia, Ru, Deng, Guochao, Yan, Huan, Fan, Mengjia, Gou, Miaomiao, Chen, Shiyun, Zhang, Nan, Shi, Yue, Qian, Niansong, Dai, Guanghai
Publicado 2022